Cargando…

Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia, Oreochromis niloticus

BACKGROUND: Vaccination is an effective and alternative means of disease prevention, however, it cannot be conducted on the offspring of fish. For this process to take place, the transfer of maternal immunity should be implemented. This study aims to determine the effectiveness of transferring immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Amrullah, Amrullah, Wahidah, Wahidah, Ardiansyah, Ardiansyah, Indrayani, Indrayani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521061/
https://www.ncbi.nlm.nih.gov/pubmed/37767359
http://dx.doi.org/10.12688/f1000research.52932.4
_version_ 1785110058031382528
author Amrullah, Amrullah
Wahidah, Wahidah
Ardiansyah, Ardiansyah
Indrayani, Indrayani
author_facet Amrullah, Amrullah
Wahidah, Wahidah
Ardiansyah, Ardiansyah
Indrayani, Indrayani
author_sort Amrullah, Amrullah
collection PubMed
description BACKGROUND: Vaccination is an effective and alternative means of disease prevention, however, it cannot be conducted on the offspring of fish. For this process to take place, the transfer of maternal immunity should be implemented. This study aims to determine the effectiveness of transferring immunity from the broodstock to the offspring using a polyvalent vaccine against Aeromonas hydrophila, Streptococcus agalactiae, and Pseudomonas fluorescens in Nile tilapia, Oreochromis niloticus. METHODS: Nile tilapia broodstock with an average weight of 203g (±SD 23) was reared in spawning ponds until mass spawning and harvested one week post-spawning for vaccination. After being vaccinated according to the treatment, each fish broodstock was reared in 3x3 m cages installed in an earthen pond with a density of 20 broodstock, consisting of 15 females and 5 males. The vaccine used was a formalin-killed whole-cell vaccine at a density of 10 (10) cfu/mL injected intramuscularly ( i.m.) at a dose of 0.4 mL/kg fish. Nile tilapia was injected with a vaccine used as a treatment. Example include A. hydrophila monovalent (MA) , S. agalactiae monovalent (MS) , P. fluorescens monovalent (MP), A. hydrophila and S. agalactiae bivalent (BAS) , A. hydrophila and P. fluorescens bivalent (BAP), P. fluorescens and S. agalactiae bivalent (BPS), and A. hydrophila, S. agalactiae, and P. fluorescens polyvalent vaccines (PAPS). While the control was fish that were injected with a PBS solution. The broodstock’s immune response was observed on the 7 (th), 14 (th), 21 (st), and 28 (th) days, while the immune response and challenge test on the offspring was conducted on the 10 (th), 20 (th), 30 (th), and 40 (th) day during the post-hatching period. The parameters observed consisted of total leukocytes, phagocytic activity, antibody titer, lysozyme, and relative survival percentage (RPS). RESULT: The application of PAPS in broodstock could significantly induce the best immune response and immunity to multiple diseases compared to other treatments. The RPS of the PAPS was also higher than the other types of vaccines. This showed that the transfer of immunity from the broodstock to the Nile tilapia offspring could protect it against bacterial diseases such as A. hydrophila, S. agalactiae, and P. fluorescens. CONCLUSION: The application of polyvalent vaccine A. hydrophila, S. agalactiae, P. fluorescens vaccines increased the broodstock’s immune response and it was transferred to their offsprings. Polyvalent vaccines derived from maternal immunity can protect offspring from disease up to 30 days of age. They were able to produce tilapia seeds that are immune to diseases caused by A. hydrophila, S. agalactiae, and P. fluorescens.
format Online
Article
Text
id pubmed-10521061
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-105210612023-11-11 Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia, Oreochromis niloticus Amrullah, Amrullah Wahidah, Wahidah Ardiansyah, Ardiansyah Indrayani, Indrayani F1000Res Research Article BACKGROUND: Vaccination is an effective and alternative means of disease prevention, however, it cannot be conducted on the offspring of fish. For this process to take place, the transfer of maternal immunity should be implemented. This study aims to determine the effectiveness of transferring immunity from the broodstock to the offspring using a polyvalent vaccine against Aeromonas hydrophila, Streptococcus agalactiae, and Pseudomonas fluorescens in Nile tilapia, Oreochromis niloticus. METHODS: Nile tilapia broodstock with an average weight of 203g (±SD 23) was reared in spawning ponds until mass spawning and harvested one week post-spawning for vaccination. After being vaccinated according to the treatment, each fish broodstock was reared in 3x3 m cages installed in an earthen pond with a density of 20 broodstock, consisting of 15 females and 5 males. The vaccine used was a formalin-killed whole-cell vaccine at a density of 10 (10) cfu/mL injected intramuscularly ( i.m.) at a dose of 0.4 mL/kg fish. Nile tilapia was injected with a vaccine used as a treatment. Example include A. hydrophila monovalent (MA) , S. agalactiae monovalent (MS) , P. fluorescens monovalent (MP), A. hydrophila and S. agalactiae bivalent (BAS) , A. hydrophila and P. fluorescens bivalent (BAP), P. fluorescens and S. agalactiae bivalent (BPS), and A. hydrophila, S. agalactiae, and P. fluorescens polyvalent vaccines (PAPS). While the control was fish that were injected with a PBS solution. The broodstock’s immune response was observed on the 7 (th), 14 (th), 21 (st), and 28 (th) days, while the immune response and challenge test on the offspring was conducted on the 10 (th), 20 (th), 30 (th), and 40 (th) day during the post-hatching period. The parameters observed consisted of total leukocytes, phagocytic activity, antibody titer, lysozyme, and relative survival percentage (RPS). RESULT: The application of PAPS in broodstock could significantly induce the best immune response and immunity to multiple diseases compared to other treatments. The RPS of the PAPS was also higher than the other types of vaccines. This showed that the transfer of immunity from the broodstock to the Nile tilapia offspring could protect it against bacterial diseases such as A. hydrophila, S. agalactiae, and P. fluorescens. CONCLUSION: The application of polyvalent vaccine A. hydrophila, S. agalactiae, P. fluorescens vaccines increased the broodstock’s immune response and it was transferred to their offsprings. Polyvalent vaccines derived from maternal immunity can protect offspring from disease up to 30 days of age. They were able to produce tilapia seeds that are immune to diseases caused by A. hydrophila, S. agalactiae, and P. fluorescens. F1000 Research Limited 2023-11-10 /pmc/articles/PMC10521061/ /pubmed/37767359 http://dx.doi.org/10.12688/f1000research.52932.4 Text en Copyright: © 2023 Amrullah A et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Amrullah, Amrullah
Wahidah, Wahidah
Ardiansyah, Ardiansyah
Indrayani, Indrayani
Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia, Oreochromis niloticus
title Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia, Oreochromis niloticus
title_full Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia, Oreochromis niloticus
title_fullStr Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia, Oreochromis niloticus
title_full_unstemmed Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia, Oreochromis niloticus
title_short Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia, Oreochromis niloticus
title_sort transfer of maternal immunity using a polyvalent vaccine and offspring protection in nile tilapia, oreochromis niloticus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521061/
https://www.ncbi.nlm.nih.gov/pubmed/37767359
http://dx.doi.org/10.12688/f1000research.52932.4
work_keys_str_mv AT amrullahamrullah transferofmaternalimmunityusingapolyvalentvaccineandoffspringprotectioninniletilapiaoreochromisniloticus
AT wahidahwahidah transferofmaternalimmunityusingapolyvalentvaccineandoffspringprotectioninniletilapiaoreochromisniloticus
AT ardiansyahardiansyah transferofmaternalimmunityusingapolyvalentvaccineandoffspringprotectioninniletilapiaoreochromisniloticus
AT indrayaniindrayani transferofmaternalimmunityusingapolyvalentvaccineandoffspringprotectioninniletilapiaoreochromisniloticus